Skip to main content
Erschienen in: Rheumatology International 4/2004

01.07.2004 | Original Article

Abnormal killer inhibitory receptor expression on natural killer cells in patients with Behçet's disease

verfasst von: Mitsuhiro Takeno, Yoshihiro Shimoyama, Jun-Ichi Kashiwakura, Hiroko Nagafuchi, Tsuyoshi Sakane, Noboru Suzuki

Erschienen in: Rheumatology International | Ausgabe 4/2004

Einloggen, um Zugang zu erhalten

Abstract

Viral infection has been assigned some role in the pathogenesis of Behçet's disease (BD). Defects in natural killer (NK) cell repertoire may be involved in impaired antiviral immunity, leading to the development of BD. We studied killer inhibitory receptor (KIR) expression in 40 patients with BD. CD94 and CD158b expression of NK cells was normal in a great majority of BD patients. NKB1 expression was reduced in eight and increased in six. Twelve of these 14 patients (86%) had severe eye disease. Some had reduced NKB1 and enhanced CD158a expression simultaneously, or enhanced NKB1 and reduced CD158a simultaneously, suggesting a skewed NK cell repertoire in BD. Collectively, KIR expression was abnormal in the BD patients with severe eye disease. This may result from genetic predisposition, or certain viruses may affect the KIR repertoire formation in BD patients. Abnormal KIR expression of NK cells may be associated with the development of BD.
Literatur
1.
Zurück zum Zitat Sakane T, Takeno M, Suzuki N, Inaba G (1999) Behçet's disease. N Engl J Med 341:1284–1291 Sakane T, Takeno M, Suzuki N, Inaba G (1999) Behçet's disease. N Engl J Med 341:1284–1291
2.
Zurück zum Zitat Gul A, Hajeer AH, Worthington J, Ollier WE, Silman AJ (2001) Linkage mapping of a novel susceptibility locus for Behçet's disease to chromosome 6p22-23. Arthritis Rheum 44:2693–2696PubMed Gul A, Hajeer AH, Worthington J, Ollier WE, Silman AJ (2001) Linkage mapping of a novel susceptibility locus for Behçet's disease to chromosome 6p22-23. Arthritis Rheum 44:2693–2696PubMed
3.
Zurück zum Zitat Eglin RP, Lehner T, Subak-Sharpe JH (1982) Detection of RNA complementary herpes simplex virus in mononuclear cells from patients with Behçet's syndrome and recurrent oral ulceration. Lancet ii:1356–1360 Eglin RP, Lehner T, Subak-Sharpe JH (1982) Detection of RNA complementary herpes simplex virus in mononuclear cells from patients with Behçet's syndrome and recurrent oral ulceration. Lancet ii:1356–1360
4.
Zurück zum Zitat Lehner T (1967) Behçet's syndrome and autoimmunity. Br Med J 1:465–467PubMed Lehner T (1967) Behçet's syndrome and autoimmunity. Br Med J 1:465–467PubMed
5.
Zurück zum Zitat Kaneko S, Suzuki N, Yamashita N, et al (1997) Characterization of T cells specific for an epitope of human 60-kD heat shock protein (hsp) in patients with Behçet's disease (BD) in Japan. Clin Exp Immunol 108:204–212 Kaneko S, Suzuki N, Yamashita N, et al (1997) Characterization of T cells specific for an epitope of human 60-kD heat shock protein (hsp) in patients with Behçet's disease (BD) in Japan. Clin Exp Immunol 108:204–212
6.
Zurück zum Zitat Suzuki N, Bianchi E, Bass H et al (1990) Natural killer lines and clones with apparent antigen specificity. J Exp Med 172:457–462PubMed Suzuki N, Bianchi E, Bass H et al (1990) Natural killer lines and clones with apparent antigen specificity. J Exp Med 172:457–462PubMed
7.
Zurück zum Zitat Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP (1999) Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol 17:189–220CrossRefPubMed Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP (1999) Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol 17:189–220CrossRefPubMed
8.
Zurück zum Zitat Mandelboim O, Lieberman N, Lev M et al (2001) Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 409:1055–1060CrossRefPubMed Mandelboim O, Lieberman N, Lev M et al (2001) Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 409:1055–1060CrossRefPubMed
9.
Zurück zum Zitat Long EO, Rajagopalan S (2000) HLA class I recognition by killer cell Ig-like receptors. Semin Immunol 12:101–108CrossRefPubMed Long EO, Rajagopalan S (2000) HLA class I recognition by killer cell Ig-like receptors. Semin Immunol 12:101–108CrossRefPubMed
10.
Zurück zum Zitat Raulet DH (2000) Development and tolerance of natural killer cells. Curr Opin Immunol 11:129–134CrossRef Raulet DH (2000) Development and tolerance of natural killer cells. Curr Opin Immunol 11:129–134CrossRef
11.
Zurück zum Zitat Cerwenka A, Lanier LL (2001) Ligands for natural killer cell receptors: redundancy or specificity. Immunol Rev 181:158–169CrossRefPubMed Cerwenka A, Lanier LL (2001) Ligands for natural killer cell receptors: redundancy or specificity. Immunol Rev 181:158–169CrossRefPubMed
12.
Zurück zum Zitat Uhrberg M, Valiante NM, Shun BP et al (1997) Human diversity in killer cell inhibitory receptor genes. Immunity 7:753–763PubMed Uhrberg M, Valiante NM, Shun BP et al (1997) Human diversity in killer cell inhibitory receptor genes. Immunity 7:753–763PubMed
13.
Zurück zum Zitat Gumperz JE, Litwin V, Phillips JH, Lanier LL, Parham P (1995) The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. J Exp Med 181:1133–1144PubMed Gumperz JE, Litwin V, Phillips JH, Lanier LL, Parham P (1995) The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. J Exp Med 181:1133–1144PubMed
14.
Zurück zum Zitat Gardiner CM, Guethlein LA, Shilling HG et al (2001) Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism. J Immunol 166:2992–3001PubMed Gardiner CM, Guethlein LA, Shilling HG et al (2001) Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism. J Immunol 166:2992–3001PubMed
15.
Zurück zum Zitat Hamzaoui K, Ayed K, Slim A, Hamza M, Touraine J (1990) Natural killer cell activity, interferon-gamma and antibodies to herpes viruses in patients with Behçet's disease. Clin Exp Immunol 79:28–34 Hamzaoui K, Ayed K, Slim A, Hamza M, Touraine J (1990) Natural killer cell activity, interferon-gamma and antibodies to herpes viruses in patients with Behçet's disease. Clin Exp Immunol 79:28–34
16.
Zurück zum Zitat Kaneko F, Takahashi Y, Muramatsu R et al (1985) Natural killer cell numbers and function in peripheral lymphoid cells in Behçet's disease. Br J Dermatol 113:313–318PubMed Kaneko F, Takahashi Y, Muramatsu R et al (1985) Natural killer cell numbers and function in peripheral lymphoid cells in Behçet's disease. Br J Dermatol 113:313–318PubMed
17.
Zurück zum Zitat Eksioglu-Demiralp E, Direskeneli H, Ergun T, Fresko I, Akoglu T (1999) Increased CD4+CD16+ and CD4+CD56+ T cell subsets in Behçet's disease. Rheumatol Int 19:23–26PubMed Eksioglu-Demiralp E, Direskeneli H, Ergun T, Fresko I, Akoglu T (1999) Increased CD4+CD16+ and CD4+CD56+ T cell subsets in Behçet's disease. Rheumatol Int 19:23–26PubMed
Metadaten
Titel
Abnormal killer inhibitory receptor expression on natural killer cells in patients with Behçet's disease
verfasst von
Mitsuhiro Takeno
Yoshihiro Shimoyama
Jun-Ichi Kashiwakura
Hiroko Nagafuchi
Tsuyoshi Sakane
Noboru Suzuki
Publikationsdatum
01.07.2004
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 4/2004
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-003-0352-x

Weitere Artikel der Ausgabe 4/2004

Rheumatology International 4/2004 Zur Ausgabe

Original Article

Brucellar spondylitis

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.